Targeting sphingolipid biosynthesis to enhance trisomy 21 cell health
Innovative approach to ameliorate cellular defects in trisomy 21 by targeting sphingolipid biosynthesis, specifically ceramide synthase, to improve cell fitness and nuclear morphology. Potentially beneficial for individu...